Merck Tbk Stock Price To Earning
| MERK Stock | IDR 3,430 10.00 0.29% |
Merck Tbk fundamentals help investors to digest information that contributes to Merck Tbk's financial success or failures. It also enables traders to predict the movement of Merck Stock. The fundamental analysis module provides a way to measure Merck Tbk's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merck Tbk stock.
Merck |
Merck Tbk Company Price To Earning Analysis
Merck Tbk's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Merck Tbk Price To Earning | 17.23 X |
Most of Merck Tbk's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merck Tbk is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Merck Tbk has a Price To Earning of 17.23 times. This is 33.32% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to earning for all Indonesia stocks is 40.01% higher than that of the company.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Merck Fundamentals
| Return On Equity | 0.23 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 2.02 T | |||
| Shares Outstanding | 448 M | |||
| Shares Owned By Insiders | 86.65 % | |||
| Shares Owned By Institutions | 2.18 % | |||
| Price To Earning | 17.23 X | |||
| Price To Book | 2.91 X | |||
| Price To Sales | 1.83 X | |||
| Revenue | 1.06 T | |||
| Gross Profit | 398.68 B | |||
| EBITDA | 203.31 B | |||
| Net Income | 131.66 B | |||
| Cash And Equivalents | 164.7 B | |||
| Cash Per Share | 367.64 X | |||
| Total Debt | 13.12 B | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 3.71 X | |||
| Book Value Per Share | 1,621 X | |||
| Cash Flow From Operations | 169.81 B | |||
| Earnings Per Share | 365.00 X | |||
| Number Of Employees | 393 | |||
| Beta | 0.72 | |||
| Market Capitalization | 2.19 T | |||
| Total Asset | 1.03 T | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 1.03 T | |||
| Last Dividend Paid | 240.0 |
About Merck Tbk Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merck Tbk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck Tbk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck Tbk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Merck Stock
Merck Tbk financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck Tbk security.